{"id":"placebo-for-oral-cab","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"A placebo is a substance or treatment that has no therapeutic effect but is used in clinical trials to compare the effects of a real treatment. In this case, the placebo is used in oral CAB clinical trials to serve as a control group.","oneSentence":"This is a placebo, meaning it has no active ingredients and is used as a control in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:21.988Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Oral CAB treatment for phase 3 clinical trials"}]},"trialDetails":[{"nctId":"NCT02720094","phase":"PHASE2, PHASE3","title":"Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-12-19","conditions":"HIV Infections","enrollment":4570},{"nctId":"NCT07479056","phase":"NA","title":"Randomized Active-Controlled Trial Evaluating Fexuprazan (Fexuclue Tab) for Prevention Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy After Coronary Intervention","status":"RECRUITING","sponsor":"SUK MIN SEO","startDate":"2024-10-24","conditions":"Diseases of the Circulatory System, Angina Pectoris, Unspecified","enrollment":400},{"nctId":"NCT07013591","phase":"PHASE2","title":"Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-03-31","conditions":"Coronary Artery Bypass Graft","enrollment":90},{"nctId":"NCT07267260","phase":"PHASE2","title":"Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"King Edward Medical University","startDate":"2025-12-16","conditions":"Cirrhoses, Liver","enrollment":154},{"nctId":"NCT05010460","phase":"PHASE2","title":"Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting","status":"TERMINATED","sponsor":"Peking Union Medical College Hospital","startDate":"2021-09-30","conditions":"Coronary Artery Bypass","enrollment":98},{"nctId":"NCT03164564","phase":"PHASE3","title":"Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-11-07","conditions":"HIV Infections","enrollment":3224},{"nctId":"NCT04493684","phase":"PHASE1","title":"GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2020-07-31","conditions":"HIV Infections","enrollment":91},{"nctId":"NCT04484337","phase":"PHASE1","title":"Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2020-07-31","conditions":"HIV Infections","enrollment":138},{"nctId":"NCT06074367","phase":"PHASE4","title":"The Impact of Oral Vitamin C in Prevention for Post Operative Atrial Fibrillation (POAF) in Coronary Artery Bypass Surgery (CABG) Patients","status":"UNKNOWN","sponsor":"Helwan University","startDate":"2020-10-13","conditions":"Post Operative Atrial Fibrillation","enrollment":180},{"nctId":"NCT01776424","phase":"PHASE3","title":"Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-02-28","conditions":"Prevention & Control","enrollment":27395},{"nctId":"NCT03939273","phase":"NA","title":"The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2022-03","conditions":"Systemic Inflammatory Response Syndrome, Postoperative Shock, Coronary Artery Disease","enrollment":80},{"nctId":"NCT02556918","phase":"PHASE4","title":"Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-01","conditions":"Hyperglycemia","enrollment":202},{"nctId":"NCT01560780","phase":"PHASE3","title":"Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2013-02-01","conditions":"Coronary Artery Bypass","enrollment":84},{"nctId":"NCT00874237","phase":"PHASE1","title":"Staccato Loxapine Thorough QT/QTc Study","status":"COMPLETED","sponsor":"Alexza Pharmaceuticals, Inc.","startDate":"2009-04","conditions":"Thorough QT/QTc Study","enrollment":48},{"nctId":"NCT03985410","phase":"PHASE1","title":"Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers","status":"COMPLETED","sponsor":"Entasis Therapeutics","startDate":"2019-05-23","conditions":"Acinetobacter Baumannii-calcoaceticus Complex Infections","enrollment":32},{"nctId":"NCT02769065","phase":"PHASE1","title":"Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants","status":"TERMINATED","sponsor":"Takeda","startDate":"2016-05-05","conditions":"Alzheimer Disease, Healthy Volunteers","enrollment":179},{"nctId":"NCT03777761","phase":"PHASE1","title":"Effects of Tucatinib on Cardiac Repolarization in Healthy Participants","status":"COMPLETED","sponsor":"Seagen Inc.","startDate":"2018-12-06","conditions":"Healthy","enrollment":55},{"nctId":"NCT01954615","phase":"PHASE1","title":"Single-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-281959 / ACT-246475 in Healthy Male Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2011-10","conditions":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics","enrollment":49},{"nctId":"NCT00246740","phase":"PHASE2","title":"Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2005-10","conditions":"Coronary Artery Bypass Grafting, Cardiopulmonary Bypass, Reperfusion Injury","enrollment":56},{"nctId":"NCT01047449","phase":"NA","title":"Improving the Results of Heart Bypass Surgery Using New Approaches to Surgery and Medication","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2011-07","conditions":"Coronary Artery Disease","enrollment":250},{"nctId":"NCT02578472","phase":"PHASE1","title":"Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2015-11","conditions":"Healthy","enrollment":36},{"nctId":"NCT01286402","phase":"PHASE2","title":"Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2011-04","conditions":"Smoking Cessation","enrollment":11},{"nctId":"NCT01158703","phase":"PHASE4","title":"Aspirin and Plavix Following Coronary Artery Bypass Grafting","status":"TERMINATED","sponsor":"Ahmad Slim","startDate":"2010-07","conditions":"Coronary Graft Patency","enrollment":20},{"nctId":"NCT00498615","phase":"PHASE3","title":"A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2007-04","conditions":"Raynaud, Scleroderma","enrollment":17},{"nctId":"NCT00623285","phase":"PHASE3","title":"The Effects of Peri-operative Pregabalin Administration on Post-operative Analgesia in Patients Undergoing Coronary Bypass Grafting","status":"UNKNOWN","sponsor":"University of Manitoba","startDate":"2008-04","conditions":"Postoperative Pain.","enrollment":40},{"nctId":"NCT00636064","phase":"PHASE3","title":"A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-01","conditions":"Pain","enrollment":1671}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for oral CAB","genericName":"Placebo for oral CAB","companyName":"National Institute of Allergy and Infectious Diseases (NIAID)","companyId":"national-institute-of-allergy-and-infectious-diseases-niaid","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo, meaning it has no active ingredients and is used as a control in clinical trials. Used for Oral CAB treatment for phase 3 clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}